Abstract
The data obtained in patients with vertigo and equilibrium disorders following β-adrenergic stimulant (dl-isoproterenol hydrochloride) and Co-enzyme Q (Ubiquinone) administration indicated that vertiginous attacks in these patients probably were the results of enhancement of the β-sympathetic system.The regional action of β-sympathetic system in β-adrenergic stimulant administration was more likely to appear with changes in excitability of the unilateral vestibular organ (in Meniere's disease) other than static dysfunction (in sensorineural hearing loss and equilibrium disorders) and effectively provided relief for the symptoms of Meniere's disease. Attacks of vertigo did follow in some patients.On the other hand, the uniform mass discharge in the sympathetic system was likely to appear in cases of β-adrenergic stimulant administration to patients with bilateral positive findings in The Mild Caloric Eye Tracking Pattern and Repeated Mild Caloric Eye tracking Pattern Tests.The results (the superimposed phenomena) in these tests revealted indications of β-adrenergic stimulant and Co-enzyme Q administration to patients with vertigo and equilibrium disorders.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.